
Nevro Corp. NVRO
Annual report 2024
added 03-04-2025
Nevro Corp. EV/EBITDA Ratio 2011-2026 | NVRO
Annual EV/EBITDA Ratio Nevro Corp.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -23.6 | -101 | -48.4 | -41.4 | -90.9 | -118 | -25.5 | -6.97 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -6.97 | -118 | -57 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
48.9 | $ 174.53 | -1.3 % | $ 13.1 B | ||
|
Alphatec Holdings
ATEC
|
-8.6 | $ 11.07 | -5.06 % | $ 1.66 B | ||
|
Bio-Rad Laboratories
BIO
|
34.5 | $ 277.5 | -1.3 % | $ 7.83 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
11 | $ 12.22 | 0.33 % | $ 1.65 B | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
EDAP TMS S.A.
EDAP
|
730 | $ 3.36 | -0.3 % | $ 126 M | ||
|
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
-2.13 | $ 37.98 | -0.71 % | $ 5.66 K | ||
|
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.6 | -2.45 % | $ 37.3 M | ||
|
Boston Scientific Corporation
BSX
|
25.2 | $ 61.28 | -2.05 % | $ 90.7 B | ||
|
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | ||
|
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | ||
|
ClearPoint Neuro
CLPT
|
-9.73 | $ 8.96 | -2.29 % | $ 254 M | ||
|
Electromed
ELMD
|
26.4 | $ 24.41 | 0.04 % | $ 206 M | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
27.6 | $ 91.4 | -0.61 % | $ 12.4 B | ||
|
Butterfly Network
BFLY
|
-3.9 | $ 4.15 | 0.24 % | $ 878 M | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-1.69 | $ 9.88 | 0.3 % | $ 354 M | ||
|
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | ||
|
Inogen
INGN
|
17.4 | $ 6.66 | -0.15 % | $ 177 M | ||
|
Inspire Medical Systems
INSP
|
-152 | $ 56.69 | 6.2 % | $ 1.66 B | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 36.93 | 0.93 % | $ 1.15 B | ||
|
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.04 | 0.97 % | $ 17.6 M | ||
|
Integer Holdings Corporation
ITGR
|
18.2 | $ 86.67 | -0.93 % | $ 3.01 B | ||
|
FONAR Corporation
FONR
|
-33.4 | $ 18.61 | -0.05 % | $ 122 M | ||
|
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
39.2 | $ 79.15 | -3.13 % | $ 46.3 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 15.94 | -0.44 % | $ 374 M | ||
|
Helius Medical Technologies
HSDT
|
-0.0925 | $ 1.89 | 0.53 % | $ 1.15 M | ||
|
LivaNova PLC
LIVN
|
215 | $ 63.37 | -2.0 % | $ 3.46 B | ||
|
LENSAR
LNSR
|
-1.48 | $ 5.46 | -1.27 % | $ 65.3 M | ||
|
Cutera
CUTR
|
236 | - | -10.19 % | $ 1.99 M |